Management of thromboembolism in the outpatient setting

Seminars in Hematology

Volumn 37, Issue 3 SUPPL. 5, 2000, Pages 23-26

  Agnelli, G ^a,b   Rossi, R ^a   Santamaria, M G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; CONFERENCE PAPER; COST CONTROL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; OUTPATIENT; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOEMBOLISM;

EID: 0033820149     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90097-0     Document Type: Conference Paper

References (14)

1. Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications: The Postarthroplasty Screening Study (PASS)
2. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
3. Prolonged thromboprophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin(TM))
4. Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism
5. Low-molecular weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis
6. Treatment of venous thrombosis with i.v. unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home
7. Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - A placebo-controlled study
8. Treatment of deep venous thrombosis with low molecular weight heparins. A meta-analysis
9. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in hospital for proximal deep-vein thrombosis
10. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting
11. Risk of deep venous thrombosis after hospital discharge in patients undergoing total hip replacement. Double-blind randomised comparison of enoxaparin versus placebo
12. Post discharge clinically overt venous thromboembolism in orthopaedic patients with negative venography - An overview analysis
13. How long after surgery does the risk of thromboembolism persist?
14. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism